PFE
Pfizer Inc
Pfizer Inc historical holders
total: 18
Yacktman Asset Management Pfizer Inc transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2013 Q2 or earlier
- Held for:
- 2+ quarters
- Latest activity:
- 2013 Q4
Donald Yacktman has been an institutional investor in Pfizer Inc (PFE) since at least 2013 Q2. According to 2026 Q1 report, Donald Yacktman doesn't hold any shares. In our earliest available record from 2013 Q2, Yacktman Asset Management held 41,700 shares of PFE. Since at least 2013 Q2, Yacktman Asset Management has made 1 more transaction in this position.
When did Donald Yacktman exit their PFE position?
Donald Yacktman no longer holds Pfizer Inc (PFE). They sold off their entire position in 2013 Q4, closing out an investment that began in 2013 Q2.
Estimated cost basis*
- Weighted AVG buy price:
- $28.01
- Weighted AVG sell price:
- $28.73
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.